Cabozantinib Ipsen 20 mg film-coated tablets

SKIPP2: Cabozantinib Dose Skipping as an Alternative to Dose Reductions

A Phase 3, Randomized, Open-label Study of Belzutifan + Zanzalintinib Versus Cabozantinib in Participants with Advanced RCC who Experienced Disease Recurrence During or After Prior Adjuvant Anti-PD-1/L1 Therapy (LITESPARK-033)